1. Home
  2. CRI vs AMPH Comparison

CRI vs AMPH Comparison

Compare CRI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$34.48

Market Cap

1.3B

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$19.00

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRI
AMPH
Founded
1865
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2002
2005

Fundamental Metrics

Financial Performance
Metric
CRI
AMPH
Price
$34.48
$19.00
Analyst Decision
Hold
Buy
Analyst Count
5
7
Target Price
$34.00
$30.29
AVG Volume (30 Days)
1.3M
581.3K
Earning Date
04-24-2026
05-06-2026
Dividend Yield
2.89%
N/A
EPS Growth
N/A
N/A
EPS
2.53
2.03
Revenue
$2,898,426,000.00
$719,887,000.00
Revenue This Year
$3.02
$7.34
Revenue Next Year
$0.77
$4.81
P/E Ratio
$13.63
$9.36
Revenue Growth
1.91
N/A
52 Week Low
$23.38
$17.03
52 Week High
$44.44
$31.26

Technical Indicators

Market Signals
Indicator
CRI
AMPH
Relative Strength Index (RSI) 42.71 32.55
Support Level $31.90 N/A
Resistance Level $39.05 $28.56
Average True Range (ATR) 1.75 1.09
MACD -0.25 -0.09
Stochastic Oscillator 50.96 32.08

Price Performance

Historical Comparison
CRI
AMPH

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: